Nebula Research & Development’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-97,107
Closed -$363K 490
2023
Q2
$363K Buy
+97,107
New +$363K 0.28% 186